Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/precigen-announces-groundbreaking-pivotal-study-data-for-prgn-2012-in-patients-with-recurrent-respiratory-papillomatosis-in-which-more-than-half-of-patients-achieved-complete-response-302161493.html
https://www.prnewswire.com/news-releases/precigen-to-host-a-webcast-on-june-3rd-to-detail-pivotal-study-results-of-prgn-2012-in-recurrent-respiratory-papillomatosis-presented-at-the-2024-asco-annual-meeting-302154722.html
https://www.prnewswire.com/news-releases/precigen-reports-first-quarter-2024-financial-results-and-business-updates-302145390.html
https://www.prnewswire.com/news-releases/precigen-to-announce-first-quarter-2024-financial-results-on-may-14th-and-host-a-conference-call-on-june-3rd-following-the-late-breaking-oral-presentation-for-prgn-2012-at-the-2024-asco-annual-meeting-302140392.html
https://www.prnewswire.com/news-releases/precigen-to-present-late-breaking-abstract-for-pivotal-phase-2-study-data-for-prgn-2012-adenoverse-immunotherapy-for-the-treatment-of-patients-with-recurrent-respiratory-papillomatosis-at-the-2024-asco-annual-meeting-302125357.html
https://www.prnewswire.com/news-releases/precigen-reports-full-year-2023-financial-results-and-business-updates-302093363.html
https://www.prnewswire.com/news-releases/precigen-receives-orphan-drug-designation-for-prgn-2012-for-the-treatment-of-recurrent-respiratory-papillomatosis-from-the-european-commission-302035305.html
https://www.prnewswire.com/news-releases/precigen-highlights-pipeline-updates-to-be-presented-at-the-42nd-annual-jp-morgan-healthcare-conference-302027869.html
https://www.prnewswire.com/news-releases/precigen-reports-third-quarter-2023-financial-results-and-progress-of-clinical-programs-301983843.html
https://www.prnewswire.com/news-releases/precigen-to-participate-in-the-stifel-2023-healthcare-conference-301979276.html